PEMBROBLAD: Real world effectiveness and safety of immune checkpoint inhibitors in patients with advanced urothelial carcinoma with histological variants.

被引：0

作者：

Amrane, Karim

Campedel, Luca

Bennamoun, Mostefa

Gabriel, Pierre-Etienne

Brouchet, Nicolas

Pouessel, Damien

Dugage, Matthieu Roulleaux

Thibault, Constance

Cancel, Mathilde

Gout, Mathilde

Flechon, Aude

Huillard, Olivier

Abbar, Baptiste

Borchiellini, Delphine

Doublet, Louis

Augusto-Pelegrin, Laetitia

Elouen, Boughalem

Moinard-Butot, Fabien

Dumont, Clement

Barthelemy, Philippe

机构：

[1] Oncol Dept, Morlaix, France

[2] CHU Clermont Ferrand, Clermont Ferrand, France

[3] Inst Mutualiste Montsouris, Paris, France

[4] Hop St Louis, Paris, France

[5] IUC Oncopole, Toulouse, France

[6] IUCT Oncopole, Inst Claudius Regaud, Toulouse, France

[7] Hop Europeen Georges Pompidou, Paris, France

[8] Univ Paris Cite, Hop Europeen Georges Pompidou, AP HP Ctr, Inst Canc Paris CARPEM,Dept Pharmacovigilance, Paris, France

[9] Univ Hosp, Dept Med Oncol, Tours, France

[10] Ctr Leon Berard, Lyon, France

[11] Univ Paris Cite, Inst Canc Paris CARPEM, Dept Med Oncol, Hop Cochin,AP HP Ctr, Paris, France

[12] Hop La Pitie Salpetriere, Paris, France

[13] Ctr Antoine Lacassagne, Nice, France

[14] Hop Prive Drome Ardeche, Valence, France

[15] CHU Rouen, Rouen, France

[16] Inst Cancerol Ouest, Angers, France

[17] ICANS Inst Cancerol Strasbourg Europe, Strasbourg, France

[18] APHP Hop St Louis, Paris, France

[19] Inst Cancerol Strasbourg Europe, Med Oncol, Strasbourg, France

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期

关键词：

261-566-9718-9794; 261-492-3532-2370-7650-2700; 261-492-2769; 613-135-244-3829; 283-9769-3573-426; 7; 3; 2; 242; 2018; 1; 38092-27449; 38092-31019; 38116-38094-8; 5;

D O I：

10.1200/JCO.2024.42.4_suppl.624

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：624 / 624

页数：1

共 50 条

[1] Real world effectiveness of systemic treatment in patients (pts) with advanced upper tract urothelial carcinoma (UTUC) with histological variants.
Moinard-Butot, Fabien
Amrane, Karim
Campedel Sr, Luca
Pouessel, Damien
Bennamoun, Mostefa
Flechon, Aude
Roulleaux Dugage, Matthieu
Gabriel Jr, Pierre-Etienne
Thibault, Constance
Abbar, Baptiste
Barbe-Richaud, Jean-Baptiste
Dumont, Clement
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
[2] Immune checkpoint inhibitors as a real hope in advanced urothelial carcinoma
Seront, Emmanuel
Catala, Gaetan
Dermine, Alexandre
Lejeune, Sarah
Rysselinck, Stephane
FUTURE SCIENCE OA, 2018, 4 (10):
[3] Comparative Effectiveness of Immune Checkpoint Inhibitors in Patients with Platinum Refractory Advanced Urothelial Carcinoma
Swami, Umang
Haaland, Benjamin
Kessel, Adam
Nussenzveig, Roberto
Maughan, Benjamin Louis
Esther, John
Sirohi, Deepika
Pal, Sumanta K.
Grivas, Petros
Agarwal, Neeraj
JOURNAL OF UROLOGY, 2021, 205 (03): : 709 - 717
[4] Comparative Effectiveness of Immune Checkpoint Inhibitors in Patients with Platinum Refractory Advanced Urothelial Carcinoma COMMENT
Soleimani, Maryam
Eigl, Bernhard J.
JOURNAL OF UROLOGY, 2021, 205 (03): : 717 - 717
[5] The Evolution of Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
Houssiau, Helene
Seront, Emmanuel
CANCERS, 2022, 14 (07)
[6] Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real-world study
Su, Ruopeng
Chen, Zeyu
Hong, Daoping
Jiang, Shuai
Yuan, Yichu
Cai, Xingyun
Hu, Hailong
Fu, Changde
Huang, Zhiyang
Wang, Zhenyu
Zheng, Bing
Huang, Jian
Wang, Zaoyu
Bao, Yige
Cai, Ming
Guo, Jianming
Chen, Minfeng
Wei, Qiang
Huang, Jiwei
Xue, Wei
CANCER MEDICINE, 2023, 12 (09): : 10587 - 10596
[7] Health-Related Quality of Life in a Real-World Cohort of Patients with Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors
Kobayashi, Hiroki
Furubayashi, Nobuki
Morihara, Kaede
Nakamura, Motonobu
Negishi, Takahito
ONCOLOGY, 2025,
[8] Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
Makrakis, Dimitrios
Bakaloudi, Dimitra Rafailia
Talukder, Rafee
Lin, Genevieve Ihsiu
Diamantopoulos, Leonidas N.
Jindal, Tanya
Vather-Wu, Naomi
Zakharia, Yousef
Tripathi, Nishita
Agarwal, Neeraj
Dawsey, Scott
Gupta, Shilpa
Lu, Eric
Drakaki, Alexandra
Liu, Sandy
Zakopoulou, Roubini
Bamias, Aristotelis
Fulgenzi, Claudia -Maria
Cortellini, Alessio
Pinato, David
Barata, Pedro
Grivas, Petros
Khaki, Ali Raza
Koshkin, Vadim S.
CLINICAL GENITOURINARY CANCER, 2023, 21 (02) : 286 - 294
[9] Efficacy and safety of disitamab vedotin in combination with immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma
Yao, Ji-Ming
Zhong, Jia-Lei
Zhou, Qiang
Guo, Ju
WORLD JOURNAL OF UROLOGY, 2025, 43 (01)
[10] Retrospective study to assess the efficacy and safety of checkpoint inhibitors in advanced urothelial carcinoma in real-world setting.
Sevillano Fernandez, Elena
Puente, Javier
Vidal, Natalia
Pinto, Alvaro
Garcia Sanchez, Lourdes
Fiorini, Aldo
Chara Velarde, Luis Enrique
Nalda Ariza, Irene
Cassinello, Javier
Rodriguez, Angel
Galvan Ruiz, Saray
Francisco Rodriguez-Moreno, Juan
Barquin, Arantzazu
Ruiz, Sergio
Navarro, Paloma
Yague, Monica
Grande, Enrique
Garcia-Donas, Jesus
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)

← 1 2 3 4 5 →